JP2011530534A5 - - Google Patents

Download PDF

Info

Publication number
JP2011530534A5
JP2011530534A5 JP2011522274A JP2011522274A JP2011530534A5 JP 2011530534 A5 JP2011530534 A5 JP 2011530534A5 JP 2011522274 A JP2011522274 A JP 2011522274A JP 2011522274 A JP2011522274 A JP 2011522274A JP 2011530534 A5 JP2011530534 A5 JP 2011530534A5
Authority
JP
Japan
Prior art keywords
spp
use according
infection
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011522274A
Other languages
English (en)
Japanese (ja)
Other versions
JP5496202B2 (ja
JP2011530534A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/053142 external-priority patent/WO2010017470A1/en
Publication of JP2011530534A publication Critical patent/JP2011530534A/ja
Publication of JP2011530534A5 publication Critical patent/JP2011530534A5/ja
Application granted granted Critical
Publication of JP5496202B2 publication Critical patent/JP5496202B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011522274A 2008-08-08 2009-08-07 C7−フルオロ置換テトラサイクリン化合物 Active JP5496202B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18830708P 2008-08-08 2008-08-08
US61/188,307 2008-08-08
PCT/US2009/053142 WO2010017470A1 (en) 2008-08-08 2009-08-07 C7-fluoro substituted tetracycline compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014041460A Division JP5690957B2 (ja) 2008-08-08 2014-03-04 C7−フルオロ置換テトラサイクリン化合物

Publications (3)

Publication Number Publication Date
JP2011530534A JP2011530534A (ja) 2011-12-22
JP2011530534A5 true JP2011530534A5 (https=) 2012-09-20
JP5496202B2 JP5496202B2 (ja) 2014-05-21

Family

ID=41110902

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2011522274A Active JP5496202B2 (ja) 2008-08-08 2009-08-07 C7−フルオロ置換テトラサイクリン化合物
JP2014041460A Expired - Fee Related JP5690957B2 (ja) 2008-08-08 2014-03-04 C7−フルオロ置換テトラサイクリン化合物
JP2015018405A Expired - Fee Related JP6041911B2 (ja) 2008-08-08 2015-02-02 C7−フルオロ置換テトラサイクリン化合物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2014041460A Expired - Fee Related JP5690957B2 (ja) 2008-08-08 2014-03-04 C7−フルオロ置換テトラサイクリン化合物
JP2015018405A Expired - Fee Related JP6041911B2 (ja) 2008-08-08 2015-02-02 C7−フルオロ置換テトラサイクリン化合物

Country Status (31)

Country Link
US (11) US8906887B2 (https=)
EP (3) EP2682387B1 (https=)
JP (3) JP5496202B2 (https=)
KR (3) KR101746795B1 (https=)
CN (3) CN102177134B (https=)
AR (3) AR072990A1 (https=)
AU (1) AU2009279473B2 (https=)
BR (1) BRPI0916985B1 (https=)
CA (1) CA2732883C (https=)
CO (1) CO6351777A2 (https=)
CY (3) CY1114689T1 (https=)
DK (2) DK2682387T3 (https=)
ES (3) ES2430254T3 (https=)
FR (1) FR19C1012I2 (https=)
HR (2) HRP20130928T1 (https=)
HU (2) HUE026562T2 (https=)
IL (3) IL211120A (https=)
LT (1) LTC2323972I2 (https=)
LU (1) LUC00107I2 (https=)
MX (2) MX358961B (https=)
NL (1) NL300971I2 (https=)
NO (1) NO2019010I1 (https=)
NZ (3) NZ591051A (https=)
PL (3) PL3000805T3 (https=)
PT (2) PT2323972E (https=)
RS (2) RS53003B (https=)
SG (1) SG10201806714PA (https=)
SI (2) SI2682387T1 (https=)
SM (1) SMT201600045B (https=)
TW (3) TWI453183B (https=)
WO (1) WO2010017470A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101746795B1 (ko) * 2008-08-08 2017-06-13 테트라페이즈 파마슈티컬스, 인코포레이티드 C7-플루오로 치환된 테트라시클린 화합물
WO2010129057A2 (en) 2009-05-08 2010-11-11 Tetraphase Pharmaceuticals, Inc. Tetracycline compounds
NO2470500T3 (https=) 2009-08-28 2018-03-03
AR082633A1 (es) * 2010-08-12 2012-12-19 Tetraphase Pharmaceuticals Inc Analogos de tetraciclina
WO2012021829A1 (en) * 2010-08-12 2012-02-16 Tetraphase Pharmaceuticals, Inc. Methods of treating bacterial infections
WO2012065028A2 (en) 2010-11-11 2012-05-18 Concert Pharmaceuticals Inc. Substituted tetracyclines
CA2883238C (en) 2012-08-31 2021-11-23 Tetraphase Pharmaceuticals, Inc. Tetracycline compounds
CN104230960B (zh) * 2013-06-06 2017-02-15 山东轩竹医药科技有限公司 四并环类间变性淋巴瘤激酶抑制剂
MA40836A (fr) * 2014-10-23 2017-08-29 Tetraphase Pharmaceuticals Inc Procédures de semi-synthèse
WO2017097891A1 (en) 2015-12-10 2017-06-15 Sandoz Ag Crystalline eravacycline
EP3778567A1 (en) 2016-01-22 2021-02-17 Sandoz Ag Crystalline eravacycline bis-hydrochloride
JP2019514952A (ja) * 2016-05-02 2019-06-06 パラテック ファーマシューティカルズ,インコーポレイテッド 9−アミノメチルミノサイクリン化合物及び尿路感染症(uti)の処置におけるその使用方法
CN107759503A (zh) * 2016-08-16 2018-03-06 四川科伦博泰生物医药股份有限公司 一种四环素衍生物及其用途
IL264878B (en) 2016-08-30 2022-06-01 Tetraphase Pharmaceuticals Inc Tetracycline compounds and methods of treatment
HUE066360T2 (hu) * 2016-10-19 2024-07-28 Tetraphase Pharmaceuticals Inc Eravaciklin kristályformái
BR112019008897A2 (pt) 2016-11-01 2019-08-13 Paratek Pharm Innc método para tratar pneumonia bacteriana adquirida na comunidade.
US12570604B2 (en) 2018-11-09 2026-03-10 Tetraphase Pharmaceuticals, Inc. Polymorphic forms of a tetracycline compound and uses thereof
CA3258444A1 (en) * 2022-05-29 2023-12-07 B. G. Negev Technologies And Applications Ltd., At Ben-Gurion University ERAVACYCLINE FOR CANCER TREATMENT

Family Cites Families (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB935384A (en) * 1959-03-30 1963-08-28 Pfizer & Co C Tetracycline derivatives and preparation thereof
US3338963A (en) * 1960-10-28 1967-08-29 American Cyanamid Co Tetracycline compounds
GB1034933A (en) 1962-10-29 1966-07-06 American Cyanamid Co 4-demethylamino-4-substituted amino 6-demethyl tetracyclines
US3304227A (en) 1965-07-15 1967-02-14 Loyal E Loveless Antibiotic-containing animal feed
US3433709A (en) * 1965-12-07 1969-03-18 American Cyanamid Co Biological transformation of alpha-6-deoxytetracyclines to tetracyclines
US4704383A (en) 1983-12-29 1987-11-03 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
USRE34656E (en) 1983-12-29 1994-07-05 The Research Foundation Of State University Of New York Use of tetracycline to enhance bone protein synthesis and/or treatment of bone deficiency
US4935412A (en) 1983-12-29 1990-06-19 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
US4925833A (en) 1983-12-29 1990-05-15 The Research Foundation Of State University Of New York Use of tetracycline to enhance bone protein synthesis and/or treatment of osteoporosis
US4666897A (en) 1983-12-29 1987-05-19 Research Foundation Of State University Inhibition of mammalian collagenolytic enzymes by tetracyclines
JP3016587B2 (ja) 1989-12-04 2000-03-06 ザ・リサーチ・ファンデーション・オブ・ステート・ユニバーシティ・オブ・ニューヨーク 非ステロイド抗炎症剤及びテトラサイクリンの配合
US5308839A (en) 1989-12-04 1994-05-03 The Research Foundation Of State University Of New York Composition comprising non-steroidal anti-inflammatory agent tenidap and effectively non-antibacterial tetracycline
US5770588A (en) 1991-02-11 1998-06-23 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions of the prevention and treatment of root caries
US5231017A (en) 1991-05-17 1993-07-27 Solvay Enzymes, Inc. Process for producing ethanol
US5494903A (en) 1991-10-04 1996-02-27 American Cyanamid Company 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
USRE40183E1 (en) 1991-10-04 2008-03-25 Wyeth Holdings Corporation 7-Substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
SG52361A1 (en) * 1991-10-04 1998-09-28 American Cyanamid Co Novel 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
US5258371A (en) 1992-05-29 1993-11-02 Kuraray Co., Ltd. Method to reduce connective tissue destruction
US6043225A (en) 1992-06-12 2000-03-28 Board Of Regents Of The University Of Washington Diagnosis and treatment of arterial chlamydial granuloma
US5420272A (en) * 1992-08-13 1995-05-30 American Cyanamid Company 7-(substituted)-8-(substituted)-9-](substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
SG47520A1 (en) * 1992-08-13 1998-04-17 American Cyanamid Co New method for the production of 9-amino-6-demethyl-6-deoxytetracycline
US5328902A (en) 1992-08-13 1994-07-12 American Cyanamid Co. 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
US5284963A (en) 1992-08-13 1994-02-08 American Cyanamid Company Method of producing 7-(substituted)-9-[(substituted glycyl)-amidol]-6-demethyl-6-deoxytetra-cyclines
DK0599397T3 (da) 1992-11-17 1996-09-16 Univ New York State Res Found Tetracycliner, herunder non-mikrobielle, kemisk-modificerede tetracycliner, inhiberer overdreven collagentværbinding ved diabetes
US5523297A (en) 1993-03-02 1996-06-04 The Research Foundation Of State University Of New York Inhibition of excessive phospholipase A2 activity and/or production by non-antimicrobial tetracyclines
US6043231A (en) 1993-03-02 2000-03-28 The Research Foundation Of State Univ. Of New York Inhibition of excessive phospholipase A2 activity and/or production by non-antimicrobial tetracyclines
US5371076A (en) * 1993-04-02 1994-12-06 American Cyanamid Company 9-[(substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines
US5668122A (en) 1993-07-28 1997-09-16 Fife; Rose S. Method to treat cancer with tetracyclines
WO1995022529A1 (en) 1994-02-17 1995-08-24 Pfizer Inc. 9-(substituted amino)-alpha-6-deoxy-5-oxy tetracycline derivatives, their preparation and their use as antibiotics
US5574026A (en) 1994-12-13 1996-11-12 American Cyanamid Company Methods for inhibiting angiogenesis proliferation of endothelial or tumor cells and tumor growth
US5843925A (en) 1994-12-13 1998-12-01 American Cyanamid Company Methods for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growth
US5495301A (en) * 1994-12-27 1996-02-27 Zenith Electronics Corporation Three wire pillow speaker with full television remote control functions
US5834449A (en) 1996-06-13 1998-11-10 The Research Foundation Of State University Of New York Treatment of aortic and vascular aneurysms with tetracycline compounds
US5827840A (en) 1996-08-01 1998-10-27 The Research Foundation Of State University Of New York Promotion of wound healing by chemically-modified tetracyclines
US5789395A (en) 1996-08-30 1998-08-04 The Research Foundation Of State University Of New York Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
US5919774A (en) 1996-12-10 1999-07-06 Eli Lilly And Company Pyrroles as sPLA2 inhibitors
US5837696A (en) 1997-01-15 1998-11-17 The Research Foundation Of State University Of New York Method of inhibiting cancer growth
US5773430A (en) 1997-03-13 1998-06-30 Research Foundation Of State University Of New York Serine proteinase inhibitory activity by hydrophobic tetracycline
US5929055A (en) 1997-06-23 1999-07-27 The Research Foundation Of State University Of New York Therapeutic method for management of diabetes mellitus
US6277061B1 (en) 1998-03-31 2001-08-21 The Research Foundation Of State University Of New York Method of inhibiting membrane-type matrix metalloproteinase
US6015804A (en) 1998-09-11 2000-01-18 The Research Foundation Of State University Of New York Method of using tetracycline compounds to enhance interleukin-10 production
US5977091A (en) 1998-09-21 1999-11-02 The Research Foundation Of State University Of New York Method of preventing acute lung injury
CA2343038A1 (en) 1998-09-28 2000-04-06 Maria Emanuel Ryan A novel inhibitor of cataract formation
US6914057B1 (en) 1998-09-28 2005-07-05 The Research Foundation Of State University Of New York Inhibitor of cataract formation
US5998390A (en) 1998-09-28 1999-12-07 The Research Foundation Of State University Of New York Combination of bisphosphonate and tetracycline
US6231894B1 (en) 1999-10-21 2001-05-15 Duke University Treatments based on discovery that nitric oxide synthase is a paraquat diaphorase
AU2000257445A1 (en) 2000-06-16 2002-01-02 Trustees Of Tufts College 7-n-substituted phenyl tetracycline compounds
WO2002004404A2 (en) 2000-07-07 2002-01-17 Trustees Of Tufts College 7,8 and 9-substituted tetracycline compounds
EA009175B1 (ru) * 2000-07-07 2007-12-28 Трастис Оф Тафтс Коллидж Замещенные соединения миноциклина, фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния млекопитающего
EP1381372A2 (en) 2001-03-14 2004-01-21 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds as synergistic antifungal agents
US6841546B2 (en) 2001-03-14 2005-01-11 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds as antifungal agents
US8088820B2 (en) 2001-04-24 2012-01-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
ES2338994T3 (es) 2001-04-24 2010-05-14 Paratek Pharmaceuticals, Inc. Compuestos de tetraciclina sustituida para el tratamiento de la malaria.
EP2327409A1 (en) 2001-07-13 2011-06-01 Paratek Pharmaceuticals, Inc. Tetracycline compound having target therapeutic activities
US20060194773A1 (en) 2001-07-13 2006-08-31 Paratek Pharmaceuticals, Inc. Tetracyline compounds having target therapeutic activities
EP2311451A1 (en) 2002-03-08 2011-04-20 Paratek Pharmaceuticals, Inc. Amino-methyl substituted tetracycline compounds
EP1503981A4 (en) 2002-03-21 2007-08-15 Paratek Pharm Innc SUBSTITUTED TETRACYCLINE COMPOUNDS
AU2003261161B2 (en) 2002-07-12 2009-09-10 Paratek Pharmaceuticals, Inc 3, 10, and 12a substituted tetracycline compounds
EP1556007A4 (en) 2002-10-24 2008-12-17 Paratek Pharm Innc SUBSTITUTED TETRACYCLINE COMPOUNDS FOR THE TREATMENT OF MALARIA
CA2503446C (en) 2002-10-24 2012-12-18 Paratek Pharmaceuticals, Inc. Methods of using substituted tetracycline compounds to modulate rna
US20050143352A1 (en) 2003-07-09 2005-06-30 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
SI1753713T1 (sl) 2004-05-21 2017-01-31 President And Fellows Of Harvard College Sinteza tetraciklinov in njihovih analogov
EP1805134B1 (en) 2004-10-25 2012-06-20 Paratek Pharmaceuticals, Inc. 4-aminotetracyclines and methods of use thereof
CA2597212A1 (en) 2005-02-04 2006-08-10 Paratek Pharmaceuticals, Inc. 11a, 12-derivatives of tetracycline compounds
MX2007009863A (es) * 2005-02-15 2007-09-04 Wyeth Corp Tetraciclinas 9-sustituidas.
US20070093455A1 (en) 2005-07-21 2007-04-26 Paul Abato 10-substituted tetracyclines and methods of use thereof
AU2007208214B2 (en) 2006-01-24 2013-02-14 Paratek Pharmaceuticals, Inc. Methods of increasing oral bioavailability of tetracyclines
WO2007117639A2 (en) 2006-04-07 2007-10-18 The President And Fellows Of Harvard College Synthesis of tetracyclines and analogues thereof
EP2431469A3 (en) 2006-05-15 2012-05-30 Paratek Pharmaceuticals, Inc. Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
US8440646B1 (en) 2006-10-11 2013-05-14 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of Bacillus anthracis infections
EP2487160B1 (en) 2006-10-11 2016-02-03 President and Fellows of Harvard College Synthesis of Enone Intermediate
AU2008239606A1 (en) 2007-04-12 2008-10-23 Paratek Pharmaceuticals, Inc. Methods for treating spinal muscular atrophy using tetracycline compounds
WO2009073056A1 (en) * 2007-09-07 2009-06-11 Dr. Reddy's Laboratories Ltd. Novel tetracycline derivatives as antibacterial agents
WO2009128913A1 (en) 2008-04-14 2009-10-22 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
KR101746795B1 (ko) * 2008-08-08 2017-06-13 테트라페이즈 파마슈티컬스, 인코포레이티드 C7-플루오로 치환된 테트라시클린 화합물
WO2010126607A2 (en) 2009-04-30 2010-11-04 President And Fellows Of Harvard College Synthesis of tetracyclines and intermediates thereto
WO2010129057A2 (en) 2009-05-08 2010-11-11 Tetraphase Pharmaceuticals, Inc. Tetracycline compounds
ES2440000T3 (es) 2009-05-08 2014-01-27 Tetraphase Pharmaceuticals, Inc. Compuestos de 8-aza-tetraciclina
NO2470500T3 (https=) 2009-08-28 2018-03-03
AR082633A1 (es) 2010-08-12 2012-12-19 Tetraphase Pharmaceuticals Inc Analogos de tetraciclina
WO2012047907A1 (en) 2010-10-04 2012-04-12 President And Fellows Of Harvard College Synthesis of c5-substituted tetracyclines, uses thereof, and intermediates thereto
CA2883238C (en) 2012-08-31 2021-11-23 Tetraphase Pharmaceuticals, Inc. Tetracycline compounds

Similar Documents

Publication Publication Date Title
JP2011530534A5 (https=)
HRP20130928T1 (hr) C7-fluor supstituirani spojevi tetraciklina
JP2013047268A5 (https=)
JP2012506870A5 (https=)
JP2013539751A5 (https=)
JP2012506871A5 (https=)
JP2013541333A5 (https=)
JP2013523761A5 (https=)
HRP20200938T1 (hr) Kombinacija koja sadrži zidovudin i polimiksin
JP2015078203A5 (https=)
JP2018500387A5 (https=)
JP2013523898A5 (https=)
JP2013542992A5 (https=)
JP2015528468A5 (https=)
Kanj et al. In vitro activity of tigecycline and comparators against Gram-positive and Gram-negative isolates collected from the Middle East and Africa between 2004 and 2011
Bonten Selective digestive tract decontamination—will it prevent infection with multidrug-resistant gram-negative pathogens but still be applicable in institutions where methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci are endemic?
JP2011528354A5 (https=)
JP2024009968A5 (https=)
JP2019501896A5 (https=)
Knysh et al. Nisin: prerequisites and prospects for application in the medical field
NZ598074A (en) Novel antibacterial hydroxyphenyl compound
JP2019534289A5 (https=)
JP2014507450A5 (https=)
WO2005037272A8 (en) Benzimidazole derivatives and use thereof as peptide deformylase inhibitors
Hwang et al. Community-acquired necrotizing pneumonia caused by ST72-SCCmec type IV-methicillin-resistant Staphylococcus aureus in Korea